Longevity Health Holdings Inc (XAGE) Quarterly and Annual Segment Results by Country and Region - CSIMarket
CSIMarket
 
Longevity Health Holdings Inc   (XAGE)

Select the Financial Report: Select the Period:


Description of Longevity Health Holdings Inc's Business Segments


The company operates as a single segment, which is managed and evaluated by the chief executive officer, the chief operating decision maker. This segment focuses on the development and commercialization of bio-aesthetic and bone and tissue healing products.


Composition of Longevity Health Holdings Inc Revenues by Segments

 
Elevai Skincare    38.38 % of total Revenue

Q2 three months ended (Jun 30 2026)
Revenues by Business Segments Revenues
(in millions $)
%
(of total Revenues)
Elevai Skincare 0.15 38.38 %
Total 0.40 100 %




Q2 three months ended (Jun 30 2026)
Revenue Growth rates by Segment Y/Y Revenue
%
Q/Q Revenue
%
Elevai Skincare - -
Total -21.37 % 1.08 %




Q2 three months ended (Jun 30 2026)
Income by Business Segments Income
(in millions $)
%
(Profit Margin)
Total -1.88 -




Q2 three months ended (Jun 30 2026)
Income Growth rates by Segment Y/Y Income
%
Q/Q Income
%
Total - -




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.